Metastasectomy and survival in kidney cancer patients
Metastasectomy is surgery to remove one or more tumours that [...]
FDA approves adjuvant pembrolizumab for intermediate-high risk kidney cancer
The Food and Drug administration (FDA) in the USA has [...]
Pazopanib for poor risk kidney cancer patients
Pazopanib is used for first-line metastatic RCC treatment, but the [...]
Selecting therapy for poor-risk advanced kidney cancer
In this video interview, Dr Earle Burgess from the Levine [...]
